≥99%HPLC Purity
COAIncluded
USAShipped
Orforglipron Capsules
Oral capsule presentation of orforglipron at 6 mg per capsule, 90 capsules per bottle. A non-peptide small-molecule GLP-1 receptor agonist — the property that makes an oral format viable.
$249.00
In stock — ships next business day
Quick Facts
| SKU | ACR-ORFO-C90 |
|---|---|
| Purity | ≥99% |
| Physical Form | Capsule |
| Storage | Store sealed at room temperature, away from light and humidity |
Research Information
Oral capsule presentation of orforglipron, supplied at 6 mg per capsule, 90 capsules per bottle.
Orforglipron is a non-peptide, small-molecule agonist of the GLP-1 receptor. Because it is not a peptide, it is not a substrate for the gastric and intestinal proteases that degrade peptide compounds before absorption. That is the reason it is studied in an oral format rather than as a reconstituted injectable.
Handling differs from a lyophilized vial: no reconstitution, no bacteriostatic water, no syringes, and no cold chain in transit. Store the sealed bottle at room temperature, away from light and humidity.
For laboratory research use only. Not for human or veterinary use.
Orforglipron is a non-peptide, small-molecule agonist of the GLP-1 receptor. Because it is not a peptide, it is not a substrate for the gastric and intestinal proteases that degrade peptide compounds before absorption. That is the reason it is studied in an oral format rather than as a reconstituted injectable.
Handling differs from a lyophilized vial: no reconstitution, no bacteriostatic water, no syringes, and no cold chain in transit. Store the sealed bottle at room temperature, away from light and humidity.
For laboratory research use only. Not for human or veterinary use.
For laboratory and research use only. This product is not for human or veterinary use. It is not a drug, supplement or food.
This product is not FDA approved for any indication, and is not intended to diagnose, treat, cure, or prevent any disease. All product information is derived from published preclinical research and does not constitute medical advice or claims.
